(ANAB) AnaptysBio - Performance -13.6% in 12m
ANAB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-8.37%
#37 in Peer-Group
Rel. Strength
26.90%
#5602 in Stock-Universe
Total Return 12m
-13.59%
#72 in Peer-Group
Total Return 5y
29.96%
#30 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 40.33 USD |
| 52 Week Low | 12.38 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.54 |
| Buy/Sell Signal +-5 | 0.82 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ANAB (-13.6%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ANAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANAB
| Total Return (including Dividends) | ANAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.02% | 3.15% | 4.01% |
| 3 Months | 52.59% | 17.08% | 17.14% |
| 12 Months | -13.59% | -11.14% | 13.46% |
| 5 Years | 29.96% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ANAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 37.2% | 52.1% | 90.3% |
| 3 Months | 82% | 79.4% | 97.5% |
| 12 Months | -52.3% | -87.4% | 46.4% |
| 5 Years | -20.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.50 | 7.63% | 6.74% |
| 3 Month | %th78.00 | 30.33% | 30.26% |
| 12 Month | %th64.50 | -2.76% | -23.84% |
| 5 Years | %th86.50 | 66.52% | -38.91% |
FAQs
Does AnaptysBio (ANAB) outperform the market?
No,
over the last 12 months ANAB made -13.59%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months ANAB made 52.59%, while XBI made 17.08%.
Performance Comparison ANAB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ANAB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 11.3% | 7% | 71.3% | -27% |
| US NASDAQ 100 | QQQ | 11.3% | 6.8% | 69.3% | -27% |
| German DAX 40 | DAX | 10.9% | 9.8% | 59.2% | -44% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.1% | 6.5% | 66.9% | -32% |
| Hongkong Hang Seng | HSI | 10.4% | 8.2% | 49.3% | -49% |
| India NIFTY 50 | INDA | 12.6% | 11.8% | 70.9% | -11% |
| Brasil Bovespa | EWZ | 15.5% | 11.7% | 56.3% | -15% |
ANAB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 12.7% | 9.3% | 68% | -37% |
| Consumer Discretionary | XLY | 10.3% | 7.7% | 79% | -32% |
| Consumer Staples | XLP | 13.3% | 11.2% | 72.3% | -21% |
| Energy | XLE | 8.3% | 6.9% | 78.9% | -16% |
| Financial | XLF | 12.7% | 8.4% | 69% | -39% |
| Health Care | XLV | 11.1% | 11% | 82.8% | -7% |
| Industrial | XLI | 10.9% | 6.6% | 65.5% | -37% |
| Materials | XLB | 10.6% | 6.5% | 70.7% | -18% |
| Real Estate | XLRE | 11.5% | 11.2% | 72.8% | -22% |
| Technology | XLK | 11.4% | 4.4% | 66.2% | -25% |
| Utilities | XLU | 11.2% | 8.4% | 67.3% | -34% |
| Aerospace & Defense | XAR | 10.6% | 4.2% | 51.3% | -63% |
| Biotech | XBI | 7.6% | 7.9% | 81.6% | -2% |
| Homebuilder | XHB | 8.2% | 2.3% | 77.9% | -13% |
| Retail | XRT | 11.3% | 7.8% | 76.1% | -20% |
ANAB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.7% | 7.72% | 85.2% | -9% |
| Natural Gas | UNG | 13% | 17.5% | 97.3% | -12% |
| Gold | GLD | 11.2% | 10.8% | 53.4% | -52% |
| Silver | SLV | 6.9% | 4.7% | 49.3% | -36% |
| Copper | CPER | 0.9% | -3.9% | 51.8% | -37% |
ANAB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 12.1% | 11.1% | 76.6% | -9% |
| iShares High Yield Corp. Bond | HYG | 11.8% | 9.9% | 74.3% | -23% |